Kane Biotech, Inc. (KNE.V)
0.03
0.00 (0.00%)
CAD |
TSXV |
Oct 23, 16:00
Kane Biotech Total Assets (Quarterly) : 2.228M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.228M |
| March 31, 2026 | 1.811M |
| September 30, 2025 | 2.741M |
| June 30, 2025 | 3.811M |
| March 31, 2025 | 2.756M |
| December 31, 2024 | 2.494M |
| September 30, 2024 | 3.905M |
| June 30, 2024 | 4.074M |
| March 31, 2024 | 5.799M |
| December 31, 2023 | |
| September 30, 2023 | 6.011M |
| June 30, 2023 | 5.582M |
| March 31, 2023 | 5.465M |
| December 31, 2022 | 5.620M |
| September 30, 2022 | 6.595M |
| June 30, 2022 | 7.413M |
| March 31, 2022 | 5.679M |
| December 31, 2021 | 6.134M |
| September 30, 2021 | 6.540M |
| June 30, 2021 | 5.736M |
| March 31, 2021 | 4.462M |
| December 31, 2020 | 5.036M |
| September 30, 2020 | 4.887M |
| June 30, 2020 | 2.666M |
| March 31, 2020 | 2.537M |
| Date | Value |
|---|---|
| December 31, 2019 | 2.756M |
| September 30, 2019 | 2.109M |
| June 30, 2019 | 2.858M |
| March 31, 2019 | 1.640M |
| December 31, 2018 | 1.556M |
| September 30, 2018 | 1.566M |
| June 30, 2018 | 1.739M |
| March 31, 2018 | 2.723M |
| December 31, 2017 | 3.397M |
| September 30, 2017 | 3.980M |
| June 30, 2017 | 1.751M |
| March 31, 2017 | 2.035M |
| December 31, 2016 | 2.131M |
| September 30, 2016 | 2.700M |
| June 30, 2016 | 3.263M |
| March 31, 2016 | 1.421M |
| December 31, 2015 | 1.173M |
| September 30, 2015 | 1.228M |
| June 30, 2015 | 1.308M |
| March 31, 2015 | 1.612M |
| December 31, 2014 | 1.989M |
| September 30, 2014 | 1.259M |
| June 30, 2014 | 1.383M |
| March 31, 2014 | 1.873M |
| December 31, 2013 | 1.884M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Quest PharmaTech, Inc. | 27.75M |
| BriaCell Therapeutics Corp. | 36.85M |
| Vaxil Bio Ltd. | 1.224M |
| Waverley Pharma, Inc. | 1.106M |
| Goldcoast Resource Corp. | 0.727M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.222M |
| Shareholders Equity (Quarterly) | -0.9939M |
| Debt to Equity Ratio | -1.975 |
| Current Ratio | 0.6141 |
| Net Debt Paydown Yield | 0.69% |